Bugge Thomas H, List Karin, Szabo Roman
Proteases and Tissue Remodeling Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA.
Front Biosci. 2007 Sep 1;12:5060-70. doi: 10.2741/2448.
Matriptase is an epithelial type II transmembrane serine protease with a complex modular structure and sophisticated activation mechanism. Reduced matriptase activity in mice or humans is associated with incomplete terminal differentiation of epidermis, epidermal appendages, oral epithelium, and, likely, other epithelial structures. Preliminary evidence indicates that matriptase is part of a serine protease zymogen activation cascade that regulates epithelial cell proliferation and fate. Matriptase activity must be tightly controlled in epithelial tissues by transcriptional and posttranslational mechanisms, as matriptase dysregulation can cause embryonic demise as well as malignant transformation.
Matriptase是一种上皮型II跨膜丝氨酸蛋白酶,具有复杂的模块化结构和精细的激活机制。小鼠或人类中matriptase活性降低与表皮、表皮附属器、口腔上皮以及可能的其他上皮结构的不完全终末分化有关。初步证据表明,matriptase是调节上皮细胞增殖和命运的丝氨酸蛋白酶原激活级联反应的一部分。由于matriptase失调可导致胚胎死亡以及恶性转化,因此必须通过转录和翻译后机制在上皮组织中严格控制matriptase活性。